White label ELPA - ClinicalTrials.eu

Study of Ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

Not recruiting

3 1 1
Investigated Diseases:
- Vitiligo
Investigated Drugs:
- Dexamethasone
+2
Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
Study of DF6002 alone and combined with nivolumab in patients with advanced solid tumors: A safety and effectiveness trial

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Df6002
- Nivolumab
Study on Long-Term Safety and Effects of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Trials

Not recruiting

3 1 1
Investigated Diseases:
- Spinal muscular atrophy
Investigated Drugs:
- Apitegromab
+1
Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Not recruiting

3 1 1 1
Investigated Drugs:
+7
Study on the Effects of Riociguat in Patients with Pulmonary Hypertension Due to Left Heart Failure

Not recruiting

2 1
Investigated Diseases:
- Pulmonary hypertension
Investigated Drugs:
- Riociguat
Study on Tocilizumab for Reducing Pain in Patients with Chronic Pancreatitis

Not recruiting

2 1 1
Investigated Drugs:
- Sodium Chloride
- Tocilizumab
Study on Monitoring Metastatic Breast Cancer Response Using Fludeoxyglucose (18F) PET/CT for Patients with Metastatic Breast Cancer

Not recruiting

4 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
- Fludeoxyglucose (18F)
Study on Induction Chemotherapy with Irinotecan, Folinic Acid, Fluorouracil, and Oxaliplatin for Patients with High-Risk Locally Advanced Rectal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Rectal cancer
Investigated Drugs:
Study on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)

Not recruiting

3 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies